Dyadic International (DYAI) Market Capitalization (2017 - 2026)
Dyadic International's (DYAI) quarterly Market Capitalization came in at $29.9 million in Q1 2026, down 26.45% year-over-year from $40.6 million in Q1 2025, and down 12.16% quarter-over-quarter from $34.0 million in Q4 2025.
Analysis
Dyadic International (DYAI) Market Capitalization (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Market Capitalization across 10 years of filings, most recently posting $29.9 million for Q1 2026.
- In Q1 2026, Market Capitalization fell 26.45% year-over-year to $29.9 million; the TTM figure through Mar 2026 stood at $29.9 million (down 26.45% YoY), while the FY2025 annual figure was $34.0 million, down 34.85% from the prior year.
- Market Capitalization came in at $29.9 million for Q1 2026 at Dyadic International, down from $34.0 million in the prior quarter.
- In the past five years, Market Capitalization ranged from a high of $86.2 million in Q2 2022 to a low of $29.8 million in Q2 2025.
- Average Market Capitalization over 5 years is $48.3 million, with a median of $46.4 million recorded in 2023.
- Year-over-year, Market Capitalization sank 72.47% in 2022 and jumped 38.76% in 2025.
- Over 5 years, Market Capitalization stood at $35.1 million in 2022, then soared by 32.03% to $46.4 million in 2023, then rose by 12.56% to $52.2 million in 2024, then tumbled by 34.85% to $34.0 million in 2025, then slipped by 12.16% to $29.9 million in 2026.
- Per Business Quant data, the three most recent Market Capitalization figures were $29.9 million in Q1 2026, $34.0 million in Q4 2025, and $42.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 29.88 Mn |
| Dec 31, 2025 | 34.02 Mn |
| Sep 30, 2025 | 42.70 Mn |
| Jun 30, 2025 | 29.83 Mn |
| Mar 31, 2025 | 40.62 Mn |
| Dec 31, 2024 | 52.21 Mn |
| Sep 30, 2024 | 30.77 Mn |
| Jun 30, 2024 | 43.63 Mn |
| Mar 31, 2024 | 48.74 Mn |
| Dec 31, 2023 | 46.39 Mn |
| Sep 30, 2023 | 55.32 Mn |
| Jun 30, 2023 | 55.61 Mn |
| Mar 31, 2023 | 51.28 Mn |
| Dec 31, 2022 | 35.13 Mn |
| Sep 30, 2022 | 54.36 Mn |
| Jun 30, 2022 | 86.21 Mn |
| Mar 31, 2022 | 85.08 Mn |
| Dec 31, 2021 | 127.60 Mn |
| Sep 30, 2021 | 156.12 Mn |
| Jun 30, 2021 | 100.80 Mn |